PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.14%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-11.95%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-4.15%
Negative EBIT growth while STERV.HE is at 112.09%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.15%
Negative operating income growth while STERV.HE is at 112.09%. Joel Greenblatt would press for urgent turnaround measures.
-2.59%
Negative net income growth while STERV.HE stands at 46.12%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.35%
Negative EPS growth while STERV.HE is at 46.15%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.35%
Negative diluted EPS growth while STERV.HE is at 46.15%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.70%
Share change of 0.70% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.84%
Diluted share count expanding well above STERV.HE's 0.05%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-55.90%
Negative OCF growth while STERV.HE is at 18.97%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-66.85%
Negative FCF growth while STERV.HE is at 21.86%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-29.30%
Negative 10Y revenue/share CAGR while STERV.HE stands at 0.01%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
22.74%
5Y revenue/share CAGR above 1.5x STERV.HE's 7.69%. David Dodd would look for consistent product or market expansions fueling outperformance.
9.81%
Positive 3Y CAGR while STERV.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
177.06%
10Y OCF/share CAGR above 1.5x STERV.HE's 55.05%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-7.70%
Negative 5Y OCF/share CAGR while STERV.HE is at 32.23%. Joel Greenblatt would question the firm’s operational model or cost structure.
10.84%
3Y OCF/share CAGR 1.25-1.5x STERV.HE's 7.60%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
302.27%
Below 50% of STERV.HE's 736.15%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
344.99%
5Y net income/share CAGR above 1.5x STERV.HE's 133.33%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
39.06%
3Y net income/share CAGR similar to STERV.HE's 40.65%. Walter Schloss would attribute it to shared growth factors or demand patterns.
50.41%
10Y equity/share CAGR at 50-75% of STERV.HE's 75.01%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
71.58%
5Y equity/share CAGR is in line with STERV.HE's 73.72%. Walter Schloss would see parallel mid-term profitability and retention policies.
30.65%
3Y equity/share CAGR at 50-75% of STERV.HE's 51.80%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.69%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
0.61%
Inventory shrinking or stable vs. STERV.HE's 9.72%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
3.38%
Asset growth above 1.5x STERV.HE's 1.78%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.29%
75-90% of STERV.HE's 6.11%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-0.20%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
3.59%
SG&A growth of 3.59% while STERV.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.